Which are the biggest biotech companies?

The biggest biotech companies depend on how you define “biggest”: market capitalization, revenue, or the size of their biotechnology businesses. The industry includes both dedicated biotech firms and large pharmaceutical companies that develop biologic drugs, gene therapies, and other biotechnology-based medicines.

The biggest biotech and biopharma companies

As of October 2026, these are some of the leading companies globally, based on market value, scale, and industry influence. Largest Biotech companies by Market CapMajor biotech companies by market cap 2026| StatistaMajor biotech & pharmaceutical companies by revenue 2026| Statista

1. Eli Lilly - United States

A global leader in diabetes, obesity, and pharmaceutical innovation, with major GLP-1 medicines such as Mounjaro and Zepbound.

2. AbbVie - United States

A major biopharmaceutical company specializing in immunology, oncology, neuroscience, and other complex diseases.

3. Roche - Switzerland

A powerhouse in biologic medicines, cancer treatment, diagnostics, and personalized healthcare.

4. Amgen - United States

One of the world's original biotechnology leaders, with expertise in biologics, inflammation, cancer, and rare diseases.

5. Johnson & Johnson - United States

A huge healthcare company with a major innovative medicines business, including oncology and immunology.

6. Merck & Co. - United States

Known for cancer immunotherapy, vaccines, and pharmaceutical research. This is the US company, not Germany's Merck KGaA.

7. Novo Nordisk - Denmark

A leading biotechnology-driven drugmaker in diabetes and obesity, including Ozempic and Wegovy.

8. Gilead Sciences - United States

A major biotech firm in HIV, antiviral medicines, and cancer treatments, including cell therapy.

9. Regeneron Pharmaceuticals - United States

A research-intensive biotechnology company focused on antibody medicines, eye diseases, immunology, and oncology.

10. Vertex Pharmaceuticals - United States

A leading specialist biotech known for cystic fibrosis medicines and expanding work in genetic diseases and cell therapies.

Biggest companies by market capitalization

For a more direct comparison, here are approximate valuations reported in October 2026. The ranking changes depending on whether broad pharmaceutical companies are included. Biggest Biotechnology Companies for Oct 2026Top U.S. Companies by Market Cap for the Biological Products, Except Diagnostic Substances IndustryLargest Healthcare Companies by Market Cap in October 2026

Approximate values, not a strict pure-biotech ranking; figures fluctuate with share prices and classification methods.

Other major biotech companies worth knowing

• BioNTech - mRNA technology and cancer immunotherapy.
• Biogen - neurological diseases.
• CSL - plasma-derived therapies and vaccines.
• Alnylam Pharmaceuticals - RNA interference medicines.
• argenx - antibody-based treatments for autoimmune diseases.
• Thermo Fisher Scientific - life-sciences equipment, laboratory products, and biopharma services rather than primarily drug development.

Which are the biggest in the biotech industry specifically?

If you mean companies whose core business is biotechnology-based drug development, rather than the entire pharmaceutical industry, start with Amgen, Gilead Sciences, Regeneron, Vertex, Moderna, and BioNTech. AbbVie is also a major biopharma leader, although its business spans a broader range of pharmaceutical products.

Are you interested in the biggest companies for investment, employment and careers, or scientific innovation? The rankings and most useful companies differ for each.

When evaluating the biggest biotech and biopharmaceutical companies, industry leaders are typically measured by market capitalization and revenue. The sector features a mix of traditional giant pharmaceutical corporations with massive biologics portfolios and pure-play biotechnology powerhouses.

The largest players in the global biotech and biopharmaceutical space include:

1. Top Global Biopharmaceutical Giants (by Market Cap)

2. Pure-Play & Specialized Biotech Leaders

While diversified giants like Eli Lilly and Johnson & Johnson dominate the top overall spots, several dedicated biotechnology companies lead in therapeutic innovation, biologics manufacturing, and market valuation:

• Amgen (USA): One of the oldest and largest pure-play biotechnology companies, known for pioneering human therapeutics in inflammation (Enbrel, Otezla) and oncology. Largest BioTech Public Companies - Multiples.vc

• Gilead Sciences (USA): A dominant force in antiviral treatments, highly recognized for its industry-leading portfolio in HIV and viral hepatitis therapies. Largest BioTech Public Companies - Multiples.vc

• Novo Nordisk (Denmark): A global leader in diabetes and chronic weight-management treatments (best known for Ozempic and Wegovy).

• Vertex Pharmaceuticals (USA): A pioneer in genetic therapies, dominating treatments for cystic fibrosis alongside expanding pipelines in gene editing and immunology.

• Regeneron Pharmaceuticals (USA): Renowned for rapid antibody discovery platforms, with major blockbusters in ophthalmology and immunology (Eylea, Dupixent).

• BioNTech (Germany) / Moderna (USA): mRNA technology leaders that scaled globally during the COVID-19 pandemic and are now applying mRNA platforms to oncology and infectious diseases.

Based on market capitalization, the largest pure-play and dedicated biotechnology companies globally include the following industry leaders:

• • Amgen Inc. (NASDAQ: AMGN) – ~ $230.4B market cap, standing as the undisputed giant in the biotech sector with a massive revenue footprint (~ $38.1B).

• Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) – ~ $126.4B market cap, renowned for its breakthrough treatments in cystic fibrosis and expanding pipeline.

• Moderna, Inc. (NASDAQ: MRNA) – ~ $90.3B market cap, a pioneer in mRNA technology platform applications.

• Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) – ~ $77.7B market cap, prominent for major commercialized antibody medicines and eye care therapies.

• Illumina, Inc. (NASDAQ: ILMN) – ~ $41.0B market cap, the dominant leader in DNA sequencing and array-based technologies.

• Biogen Inc. (NASDAQ: BIIB) – ~ $34.4B market cap, long-established leader specializing in neurology and neurodegenerative diseases.

• Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) – ~ $30.0B market cap, a pioneer in RNA interference (RNAi) therapeutics.

(Note: Mega-cap pharmaceutical companies like Eli Lilly, Johnson & Johnson, and Pfizer also have massive biotech portfolios and therapies, but the list above focuses on standalone or dedicated biotechnology sector leaders.)

Would you like to explore financial metrics , pipeline drugs , or recent performance trends for any specific company on this list?

“Biggest” depends on how you measure it. By market capitalization, a 2026 ranking lists Eli Lilly, Johnson & Johnson, AbbVie, Roche, AstraZeneca, and Novartis among the largest; rankings vary depending on whether broad pharmaceutical companies are counted as biotech.(capital.com)

The biggest biotech companies in 2026 include Amgen, Vertex Pharmaceuticals, Moderna, Regeneron, and Gilead Sciences, alongside global leaders like Eli Lilly, Roche, and Novartis. These firms dominate by market capitalization, revenue, and influence in drug development, particularly in areas like oncology, genetic medicine, and immunology.Top 30 Biotechnology Firms 2026 | Healthcare Ranking - The Economy RankingsTop 50 Companies in Biotech (2026) | Worth & Revenue | CompWorthLargest Biotechnology Stocks by Market Cap (2026) | Dividend DataLargest Biotech Companies by Market Cap 2026 | Capital.com

🌍 Largest Biotech Companies (2026)

🔑 Key Insights

• Traditional pharma giants (Eli Lilly, Roche, Novartis) are now considered biotech leaders because much of their revenue comes from biologics, gene therapies, and advanced platforms.

• Pure-play biotech firms (Amgen, Vertex, Moderna, Regeneron, Gilead) remain central innovators, often specializing in narrower therapeutic areas but with blockbuster drugs.

• Emerging leaders include argenx, BioNTech, Genmab, and Alnylam, which focus on niche areas like rare diseases, RNA therapeutics, and immunology.Top 30 Biotechnology Firms 2026 | Healthcare Ranking - The Economy Rankings

⚠️ Risks & Considerations

• Patent cliffs: AbbVie and Amgen face revenue risks as blockbuster drugs lose exclusivity.Top Biotech Companies 2026: Investment Analysis, Clinical Breakthroughs, and M&A Targets - Axis Intelligence

• Competition in obesity drugs: Eli Lilly’s dominance in GLP-1 therapies has pressured Novo Nordisk’s market cap.Top Biotech Companies 2026: Investment Analysis, Clinical Breakthroughs, and M&A Targets - Axis Intelligence

• Regulatory hurdles: Gene therapy and CRISPR-based treatments face long approval timelines and high costs.

• Volatility : Biotech stocks are highly sensitive to clinical trial results and FDA decisions.

Would you like me to focus on pure biotech firms only (like Amgen, Vertex, Moderna) or include pharma-biotech hybrids (like Eli Lilly, Roche, Novartis) in more detail? This distinction changes the “biggest” list significantly.